ArticleAlzheimer's research & therapy2026

Are pre-frail and frail amyloid positive individuals eligible to Lecanemab? A cross-sectional analysis from the Cogfrail real-world cohort.

Federico Bellelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.